Finally, a prognostic signature based on nine ARGs (HSP90AA1, NFKB2, PLAU, PTK2, RECQL4, CLU, JAK2, MAP3K5, and S100B) were built based on 1046 patients with BC in the training set. This evidence concerns the gene PTK2 and breast cancer.